Twinlab
This article was originally published in The Tan Sheet
Executive Summary
Company will take a fourth quarter charge of $500,000 due to a 12% reduction in its 1,200-member workforce through terminations and attrition, firm announces Dec. 19. Personnel cuts, which do not target any particular segment or division, are part of a new plan to increase operating efficiencies and reduce overhead. Hauppauge, N.Y.-based company also is streamlining and consolidating administration and operations for its catalog and direct-sales divisions. "Modest" price increases in 2001 on approximately 10% of Twinlab products also should be expected, Twinlab tells its distributors. The firm is currently facing shareholder lawsuits stemming from sales declines and inventory discrepancies (1"The Tan Sheet" Dec. 4, 2000, In Brief)
You may also be interested in...
Twinlab
Securities class actions filed against supplement firm and its officers in Islip, N.Y. federal court on behalf of purchasers of Twinlab stock between April 27, 1999 and Nov. 15, 2000. The lawsuits generally allege defendants issued materially false and misleading financial statements and misrepresented sales growth potential, particularly for herbals. The complaints also assert the firm overstated its physical inventory, and that Twinlab stock was artificially inflated as a result of these disclosure violations. On Nov. 15, Twinlab announced product returns from "major customers" and "inventory reduction" in the herbals and sport nutritional markets forced it to lower FY 2000 projections. The company's 10-Q filing with SEC had been delayed due to inventory discrepancies (1"The Tan Sheet" Nov. 20, p. 5)
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands